Ibrance - NDC Database

12 records found

Page:1

0069-0187 Feb 03, 2015
Ibrance 75 mg Oral Capsule by Pfizer Laboratories Div Pfizer Inc

0069-0188 Feb 03, 2015
Ibrance 100 mg Oral Capsule by Pfizer Laboratories Div Pfizer Inc

0069-0189 Feb 03, 2015
Ibrance 125 mg Oral Capsule by Pfizer Laboratories Div Pfizer Inc

0069-0284 Mar 30, 2020
Ibrance 75 mg Oral Tablet, Film Coated by Pfizer Laboratories Div Pfizer Inc

0069-0486 Mar 30, 2020
Ibrance 100 mg Oral Tablet, Film Coated by Pfizer Laboratories Div Pfizer Inc

0069-0688 Mar 30, 2020
Ibrance 125 mg Oral Tablet, Film Coated by Pfizer Laboratories Div Pfizer Inc

63539-187 May 08, 2017
Ibrance 75 mg Oral Capsule by U.S. Pharmaceuticals

63539-188 May 08, 2017
Ibrance 100 mg Oral Capsule by U.S. Pharmaceuticals

63539-189 Feb 03, 2015
Ibrance 125 mg Oral Capsule by U.S. Pharmaceuticals

63539-284 Mar 30, 2020
Ibrance 75 mg Oral Tablet, Film Coated by Us Pharmaceuticals

63539-486 Mar 30, 2020
Ibrance 100 mg Oral Tablet, Film Coated by Us Pharmaceuticals

63539-688 Mar 30, 2020
Ibrance 125 mg Oral Tablet, Film Coated by Us Pharmaceuticals

Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.